Suchergebnisse - "Kast, Richard E"

PubPharm (10)

1

MDACT : A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen

enthalten in: Cancers | 2022

von Kast, R. | Alfieri, A. | Assi, H. | +10

2

OPALS : A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs

enthalten in: Cells | 2021

von Kast, R. | Halatsch, M. | Rosell, R.

3

Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation

enthalten in: Medical sciences (Basel, Switzerland) | 2021

von Kast, R.

4

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma : CUSP9v3

enthalten in: Neuro-oncology advances | 2021

von Halatsch, M. | Kast, R. | Karpel-Massler, G. | +19

5

A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas : 5-ALA Augmented Irradiation, the 5aai Regimen

enthalten in: Brain sciences | 2020

von Kast, R. | Michael, A. | Sardi, I. | +5

6

Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat : The CAALA Regimen

enthalten in: Brain sciences | 2018

von Kast, R. | Skuli, N. | Sardi, I. | +6

7

Paths for Improving Bevacizumab Available in 2018 : The ADZT Regimen for Better Glioblastoma Treatment

enthalten in: Medical sciences (Basel, Switzerland) | 2018

von Kast, R.

8

Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs : the EIS regimen

enthalten in: Oncotarget | 2017

von Kast, R. | Skuli, N. | Karpel-Massler, G. | +3

9

Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression : Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2017

von Kast, R. | Hill, Q. | Wion, D. | +5

10

Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers

enthalten in: Contemporary oncology (Poznan, Poland) | 2015

von Kast, R.

1
[1]